(Q37375491)

English

Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

adaptive radiation therapy

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

Cécile Proust-Lima

1

object named as

Cécile Proust-Lima

0 references

object named as

Donna P Ankerst

4

0 references

author name string

Cécile Proust-Lima

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jeremy M G Taylor

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Scott G Williams

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ning Liu

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Larry L Kestin

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kyounghwa Bae

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Howard M Sandler

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

1 November 2008

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

72

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

782-791

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

6 September 2017

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

6 September 2017

Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

6 September 2017

What to do for prostate cancer patients with a rising PSA?--A survey of Australian practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

6 September 2017

Random-effects models for longitudinal data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

6 September 2017

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

14 September 2017

Individualized predictions of disease progression following radiation therapy for prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

14 September 2017

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

28 September 2017

Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

26 June 2018

Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

2 September 2018

Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant a

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

2 September 2018

Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

2 September 2018

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

2 September 2018

Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

2 September 2018

Does age influence the behaviour of localized prostate cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

2 September 2018

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2757130

2 September 2018

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PSA failure and the risk of death in prostate cancer patients treated with radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose response in prostate cancer with 8-12 years' follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations

1 reference

https://pubmed.ncbi.nlm.nih.gov/19014779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2008.01.056

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37375491&oldid=1702794971"